drugset / Trial / NCT01585792
Double Blind Comparative Study of TAK-875
Treatment
Summary
The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fasiglifam | Small molecule | 25 mg | — |
| Subject | Fasiglifam | Small molecule | 50 mg | — |
| Comparator | Glimepiride | Small molecule | — | — |
Indications
No indication recorded.